Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,973 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomised controlled study of the reactogenicity of an acellular pertussis-containing pentavalent infant vaccine compared to a quadrivalent whole cell pertussis-containing vaccine and oral poliomyelitis vaccine, when given concurrently with meningococcal group C conjugate vaccine to healthy UK infants at 2, 3 and 4 months of age.
Kitchin N, Southern J, Morris R, Hemme F, Cartwright K, Watson M, Miller E. Kitchin N, et al. Among authors: morris r. Vaccine. 2006 May 1;24(18):3964-70. doi: 10.1016/j.vaccine.2006.02.018. Epub 2006 Feb 21. Vaccine. 2006. PMID: 16517034 Clinical Trial.
Antibody persistence in UK pre-school children following primary series with an acellular pertussis-containing pentavalent vaccine given concomitantly with meningococcal group C conjugate vaccine, and response to a booster dose of an acellular pertussis-containing quadrivalent vaccine.
Kitchin N, Southern J, Morris R, Borrow R, Fiquet A, Boisnard F, Thomas S, Miller E. Kitchin N, et al. Among authors: morris r. Vaccine. 2009 Aug 13;27(37):5096-102. doi: 10.1016/j.vaccine.2009.06.049. Epub 2009 Jun 30. Vaccine. 2009. PMID: 19573637 Clinical Trial.
Evaluation of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b vaccine given concurrently with meningococcal group C conjugate vaccine at 2, 3 and 4 months of age.
Kitchin NR, Southern J, Morris R, Hemme F, Thomas S, Watson MW, Cartwright K, Miller E. Kitchin NR, et al. Among authors: morris r. Arch Dis Child. 2007 Jan;92(1):11-6. doi: 10.1136/adc.2005.076109. Epub 2006 May 2. Arch Dis Child. 2007. PMID: 16670121 Free PMC article. Clinical Trial.
A randomized study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide--CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challenge phase.
Riddell A, Buttery JP, McVernon J, Chantler T, Lane L, Bowen-Morris J, Diggle L, Morris R, Lockhart S, Pollard AJ, Cartwright K, Moxon ER. Riddell A, et al. Among authors: morris r. Vaccine. 2007 May 10;25(19):3906-12. doi: 10.1016/j.vaccine.2007.01.097. Epub 2007 Feb 7. Vaccine. 2007. PMID: 17368663 Clinical Trial.
Immunogenicity of a fourth dose of Haemophilus influenzae type b (Hib) conjugate vaccine and antibody persistence in young children from the United Kingdom who were primed with acellular or whole-cell pertussis component-containing Hib combinations in infancy.
Southern J, McVernon J, Gelb D, Andrews N, Morris R, Crowley-Luke A, Goldblatt D, Miller E. Southern J, et al. Among authors: morris r. Clin Vaccine Immunol. 2007 Oct;14(10):1328-33. doi: 10.1128/CVI.00191-07. Epub 2007 Aug 15. Clin Vaccine Immunol. 2007. PMID: 17699835 Free PMC article. Clinical Trial.
Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom.
Southern J, Borrow R, Andrews N, Morris R, Waight P, Hudson M, Balmer P, Findlow H, Findlow J, Miller E. Southern J, et al. Among authors: morris r. Clin Vaccine Immunol. 2009 Feb;16(2):194-9. doi: 10.1128/CVI.00420-08. Epub 2008 Dec 17. Clin Vaccine Immunol. 2009. PMID: 19091990 Free PMC article. Clinical Trial.
4,973 results